Heart Failure Society of America Delivering In-Person Review Course for Physicians Pursuing and Maintaining Advanced Heart Failure and Transplant Cardiology Board Certification in 2024

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

WASHINGTON, June 27, 2024 /PRNewswire/ — The Heart Failure Society of America (HFSA) is a leading provider of education and professional development resources for clinicians treating patients with heart failure in the United States. To support these clinicians as they apply for initial Advanced Heart Failure and Transplant Cardiology (AHFTC) certification or re-certification with the America Board of Internal Medicine (ABIM), HFSA will host its AHFTC Board Certification Review July 12-14 in Chicago, Illinois at Loews Chicago O’Hare. This is the only in-person course to support clinicians in the AHFTC subspecialty taking place in 2024, to align with ABIM’s exam date on November 6, 2024.

The HFSA AHFTC Board Certification Review features 2.5 days of lectures, discussions and Q&As, with educational content built on the ABIM AHFTC certification exam blueprint and serving as an in-depth review of the key concepts, guidelines, and clinical practices outlined in the exam. Participants can earn up to 24.50 AMA PRA Category 1 Credits™. Several additional resources will provide participants with a toolbox they can use to study right up until test time.

Participants of the HFSA AHFTC Board Certification Review will receive these takeaway tools and resources:

  • Significant facetime with a faculty of over 20 heart failure experts, including lunchtime discussions
  • Online Question Bank, with questions formatted in ABIM-style
  • OnDemand access to in-person presentations post-meeting
  • Pre-recorded webinars available before and after the live course
  • Interactive session with HARVI, a simulation-based tool for learning about cardiovascular physiology, hemodynamics and therapeutics
  • Curated Reading List

The HFSA AHFTC Board Certification Review is conveniently being held in Chicago right near the airport, to allow for easy travel to and from the course, and to minimize clinicians’ time away from home and work.

For more information on the event, visit hfsa.org/boardreview2024.

About the Heart Failure Society of America

The Heart Failure Society of America, Inc. (HFSA) represents the first organized effort by heart failure experts from the Americas to provide a forum for all those interested in heart function, heart failure, and congestive heart failure (CHF) research and patient care. The mission of HFSA is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research, and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.

Media Contact: Laura Poko, 301-798-4493, ext. 226, lpoko@hfsa.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/heart-failure-society-of-america-delivering-in-person-review-course-for-physicians-pursuing-and-maintaining-advanced-heart-failure-and-transplant-cardiology-board-certification-in-2024-302183895.html

SOURCE Heart Failure Society of America

Staff

Recent Posts

NJ Rallies Investment Power, Leveraging Capital from Garden State Venture Partners to Drive MedTech and Maternal Health Innovation

GLASSBORO, N.J.--(BUSINESS WIRE)--Two transformative healthcare announcements this week mark a new era for New Jersey’s…

5 hours ago

Revival Healthcare Capital Announces Strategic Partnership to Accelerate External Innovation in Robotics With up to $458 Million Joint Investment With Olympus Into Co-Founded New Company Swan EndoSurgical

AUSTIN, Texas--(BUSINESS WIRE)--Revival Healthcare Capital (Revival), an investment firm focused on transformative external innovation partnerships…

5 hours ago

Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7

NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to…

8 hours ago

HCA Healthcare Reports Second Quarter 2025 Results

Raises 2025 GuidanceNASHVILLE, Tenn.--(BUSINESS WIRE)--HCA Healthcare, Inc. (NYSE: HCA) today announced financial and operating results…

8 hours ago

Numinus Wellness Inc. Announces Fourth Quarter Fiscal 2024 Results

Q4 Fiscal 2024 Highlights1Revenue of $1.2 million, a 16.4% increase over Q3 2024Gross profit of…

8 hours ago

Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds

King of Prussia, Pennsylvania--(Newsfile Corp. - July 25, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO),…

11 hours ago